756 related articles for article (PubMed ID: 9349299)
1. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
[TBL] [Abstract][Full Text] [Related]
2. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
[TBL] [Abstract][Full Text] [Related]
3. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
[TBL] [Abstract][Full Text] [Related]
4. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
[TBL] [Abstract][Full Text] [Related]
5. The impact of previous HBV infection on the course of chronic hepatitis C.
De Maria N; Colantoni A; Friedlander L; Leandro G; Idilman R; Harig J; Van Thiel DH
Am J Gastroenterol; 2000 Dec; 95(12):3529-36. PubMed ID: 11151889
[TBL] [Abstract][Full Text] [Related]
6. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
[TBL] [Abstract][Full Text] [Related]
7. Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment.
Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Stanzione M; Filippini P; Felaco FM; Piccinino F
J Med Virol; 2001 Dec; 65(4):681-7. PubMed ID: 11745931
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
[TBL] [Abstract][Full Text] [Related]
9. Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes.
Selim HS; Abou-Donia HA; Taha HA; El Azab GI; Bakry AF
Eur J Intern Med; 2011 Apr; 22(2):187-90. PubMed ID: 21402251
[TBL] [Abstract][Full Text] [Related]
10. Semiquantitative anti-HBc IgM detection in children with chronic hepatitis B: a long-term follow-up study.
Gaeta GB; Nardiello S; Pizzella T; Russo G; Maisto A; Sardaro C; Galanti B; Giusti G
J Med Virol; 1995 Jul; 46(3):173-7. PubMed ID: 7561786
[TBL] [Abstract][Full Text] [Related]
11. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses.
Guptan RC; Thakur V; Raina V; Sarin SK
J Gastroenterol Hepatol; 1999 Sep; 14(9):893-8. PubMed ID: 10535471
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.
Levast M; Larrat S; Thelu MA; Nicod S; Plages A; Cheveau A; Zarski JP; Seigneurin JM; Morand P; Leroy V
J Med Virol; 2010 May; 82(5):747-54. PubMed ID: 20336715
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
14. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
[TBL] [Abstract][Full Text] [Related]
15. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.
Weltman MD; Brotodihardjo A; Crewe EB; Farrell GC; Bilous M; Grierson JM; Liddle C
J Viral Hepat; 1995; 2(1):39-45. PubMed ID: 7493293
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.
Drosten C; Nippraschk T; Manegold C; Meisel H; Brixner V; Roth WK; Apedjinou A; Günther S
J Clin Virol; 2004 Jan; 29(1):59-68. PubMed ID: 14675872
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.
Loggi E; Gitto S; Galli S; Minichiello M; Conti F; Grandini E; Scuteri A; Vitale G; Di Donato R; Cursaro C; Furlini G; Andreone P
J Clin Virol; 2017 Aug; 93():66-70. PubMed ID: 28654775
[TBL] [Abstract][Full Text] [Related]
19. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
[TBL] [Abstract][Full Text] [Related]
20. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.
Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Filippini P; Piccinino F
J Med Virol; 2001 Jul; 64(3):350-5. PubMed ID: 11424125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
